Emad Siddiqui

Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience

Adrian Wagg, Gerhard Compion, Amanda Fahey et al. · British Journal of Urology · 2012 · 318 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase <scp>III</scp> studies

V. Khullar, Philip E.V. van Kerrebroeck, Sender Herschorn et al. · International Journal of Clinical Practice · 2013 · 211 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden

Rossella E. Nappi, Robin Kroll, Emad Siddiqui et al. · Menopause The Journal of The North American Menopause Society · 2021 · 207 citations · Full text

Nursing, Endocrinology, Health Assessment +15

Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice

Christopher R. Chapple, Jameel Nazir, Zalmaï Hakimi et al. · European Urology · 2017 · 202 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

Marcus J. Drake, Christopher R. Chapple, Adil Esen et al. · European Urology · 2016 · 183 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17